Publications

Lexis®PSL IP & IT - Living costs: Crown use and the cost of pharmaceuticals

Lexis®PSL IP & IT - Living costs: Crown use and the cost of pharmaceuticals

Published By Dr Penny Gilbert

12/11/2015 13:11:56

After the NHS dropped the life-prolonging drug Kadcyla due to the expense, many are fighting for the patent to be torn up and a generic copy of Kadcyla to be imported or manufactured. 

Read Lexis PSL interview with Penny Gilbert which discusses the use of patents and Crown use following the public campaign urging the Health Secretary to allow cheaper breast cancer drugs.